ScholarIQanswers from OpenAlex & ORCID
Anatole Besarab
ResearcherPublications, citations & collaboration network
Anatole Besarab is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anatole Besarab have?
ScholarIQindexed works
Anatole Besarab has 276 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anatole Besarab have?
ScholarIQcitation count
Anatole Besarab has 13,167 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anatole Besarab?
ScholarIQh-index
Anatole Besarab has an h-index of 56 in OpenAlex.
What is the i10-index of Anatole Besarab?
ScholarIQi10-index
Anatole Besarab has an i10-index of 145 in OpenAlex.
What is the OpenAlex record for Anatole Besarab?
ScholarIQopenalex
The OpenAlex for Anatole Besarab is on the source record.
What are the most-cited papers on Anatole Besarab?
ScholarIQmost cited works
The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin
Anatole Besarab, W. Kline Bolton, Jeffrey K. Browne, Joan C. Egrie, Allen R. Nissenson, Douglas M. Okamoto, Steve J. Schwab, David A. Goodkin
Recommended standards for reports dealing with arteriovenous hemodialysis accesses
Anton N. Sidawy, Richard Gray, Anatole Besarab, Mitchell L. Henry, Enrico Ascher, Michael Silva, Arnold Miller, Larry A. Scher, Scott O. Trerotola, Roger T. Gregory, Robert B. Rutherford, K. Craig Kent
The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access
Anton N. Sidawy, Lawrence M. Spergel, Anatole Besarab, Michael Allon, William C. Jennings, Frank T. Padberg, M. Hassan Murad, Víctor M. Montori, Ann M. O’Hare, Keith D. Calligaro, Robyn Macsata, Alan B. Lumsden, Enrico Ascher
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Gregorio T. Obrador, Carol A. Pollock, Peter Stenvinkel, Dorine W. Swinkels, Christoph Wanner, Günter Weiß, Glenn M. Chertow, John W. Adamson, Tadao Akizawa, Stefan D. Anker, Michael Auerbach, Peter Bárány, Anatole Besarab, Sunil Bhandari, Ioav Cabantchik, Alan J. Collins, Daniel W. Coyne, Ángel L.M. de Francisco, Steven Fishbane, Sandrine Gaillard, Tomas Ganz, David Goldsmith, Chaim Hershko, Ewa A. Jankowska, Kirsten L. Johansen, Kamyar Kalantar‐Zadeh, Philip A. Kalra, Bertram L. Kasiske, Francesco Locatelli, Jolanta Małyszko, Gert Mayer, Lawrence P. McMahon, Ashraf Mikhail, Elizabeta Nemeth, Amy Barton Pai, Patrick S. Parfrey, Roberto Pecoits‐Filho, Simon D. Roger, Guy Rostoker, Jacques Rottembourg, Ajay Singh, Itzchak Slotki, Bruce Spinowitz, Der‐Cherng Tarng, Francesca Tentori, Jorge E. Toblli, Yusuke Tsukamoto, Nosratola D. Vaziri, Wolfgang C. Winkelmayer, David C. Wheeler, Elena Zakharova
Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
Robert Provenzano, Anatole Besarab, Chao Sun, Susan A. Diamond, John H. Durham, José L. Cangiano, Joseph R. Aiello, James E. Novak, Tyson Lee, Robert Leong, Brian K. Roberts, Khalil G. Saikali, Stefan Hemmerich, Lynda A. Szczech, Kin-Hung P. Yu, Thomas B. Neff